BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borse V, Al Aameri RFH, Sheehan K, Sheth S, Kaur T, Mukherjea D, Tupal S, Lowy M, Ghosh S, Dhukhwa A, Bhatta P, Rybak LP, Ramkumar V. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death Dis 2017;8:e2921. [PMID: 28703809 DOI: 10.1038/cddis.2017.314] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Barberino RS, Lins TLBG, Monte APO, Silva RLS, Andrade KO, Campinho DSP, Palheta Junior RC, Smitz JEJ, Matos MHT. Epigallocatechin-3-gallate attenuates cyclophosphamide-induced damage in mouse ovarian tissue via suppressing inflammation, apoptosis, and expression of phosphorylated Akt, FOXO3a and rpS6. Reprod Toxicol 2022;113:42-51. [PMID: 35981663 DOI: 10.1016/j.reprotox.2022.08.010] [Reference Citation Analysis]
2 Domingo IK, Latif A, Bhavsar AP. Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity. IJMS 2022;23:7227. [DOI: 10.3390/ijms23137227] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen Y, Gu J, Liu Y, Xu K, Song J, Wang X, Yu D, Wu H. Epigallocatechin gallate-loaded tetrahedral DNA nanostructures as a novel inner ear drug delivery system. Nanoscale 2022;14:8000-11. [PMID: 35587814 DOI: 10.1039/d1nr07921b] [Reference Citation Analysis]
4 Lee DS, Schrader A, Warchol M, Sheets L. Cisplatin exposure acutely disrupts mitochondrial bioenergetics in the zebrafish lateral-line organ. Hearing Research 2022. [DOI: 10.1016/j.heares.2022.108513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 He Y, Zheng Z, Liu C, Li W, Zhao L, Nie G, Li H. Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway. Acta Pharm Sin B 2022;12:1305-21. [PMID: 35530135 DOI: 10.1016/j.apsb.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bu C, Xu L, Han Y, Wang M, Wang X, Liu W, Chai R, Wang H. c-Myb protects cochlear hair cells from cisplatin-induced damage via the PI3K/Akt signaling pathway. Cell Death Discov 2022;8:78. [PMID: 35210433 DOI: 10.1038/s41420-022-00879-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Nan B, Zhao Z, Jiang K, Gu X, Li H, Huang X. Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo. Acta Pharm Sin B 2022;12:167-81. [PMID: 35127378 DOI: 10.1016/j.apsb.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ramkumar V, Mukherjea D, Dhukhwa A, Rybak LP. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity. Antioxidants (Basel) 2021;10:1919. [PMID: 34943021 DOI: 10.3390/antiox10121919] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Wang Q, Shen Y, Pan Y, Chen K, Ding R, Zou T, Zhang A, Guo D, Ji P, Fan C, Mei L, Hu H, Ye B, Xiang M. Tlr2/4 Double Knockout Attenuates the Degeneration of Primary Auditory Neurons: Potential Mechanisms From Transcriptomic Perspectives. Front Cell Dev Biol 2021;9:750271. [PMID: 34760891 DOI: 10.3389/fcell.2021.750271] [Reference Citation Analysis]
10 Gu J, Tong L, Lin X, Chen Y, Wu H, Wang X, Yu D. The disruption and hyperpermeability of blood-labyrinth barrier mediates cisplatin-induced ototoxicity. Toxicol Lett 2021;354:56-64. [PMID: 34757176 DOI: 10.1016/j.toxlet.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ayral M, Toprak SF. The effects of ethyl pyruvate against experimentally induced cisplatin ototoxicity in rats. Somatosens Mot Res 2021;38:347-52. [PMID: 34635013 DOI: 10.1080/08990220.2021.1984875] [Reference Citation Analysis]
12 Zong Y, Chen F, Li S, Zhang H. (-)-Epigallocatechin-3-gallate (EGCG) prevents aminoglycosides-induced ototoxicity via anti-oxidative and anti-apoptotic pathways. Int J Pediatr Otorhinolaryngol 2021;150:110920. [PMID: 34500358 DOI: 10.1016/j.ijporl.2021.110920] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Domarecka E, Skarzynska M, Szczepek AJ, Hatzopoulos S. Use of zebrafish larvae lateral line to study protection against cisplatin-induced ototoxicity: A scoping review. Int J Immunopathol Pharmacol 2020;34:2058738420959554. [PMID: 33084473 DOI: 10.1177/2058738420959554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu P, Wu X, Zhang C, Chen X, Huang Y, Li H. Hair Cell Protection from Ototoxic Drugs. Neural Plast 2021;2021:4909237. [PMID: 34335732 DOI: 10.1155/2021/4909237] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Liu Y, Wu H, Zhang F, Yang J, He J. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis. Biochem Cell Biol 2021;99:385-95. [PMID: 34077275 DOI: 10.1139/bcb-2020-0459] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Nishimura T, Okayasu T, Yamashita A, Hosoi H, Kitahara T. Perception Mechanism of Bone-Conducted Ultrasound and Its Clinical Use. Audiol Res 2021;11:244-53. [PMID: 34070877 DOI: 10.3390/audiolres11020022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dhukhwa A, Al Aameri RFH, Sheth S, Mukherjea D, Rybak L, Ramkumar V. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss. Sci Rep 2021;11:8116. [PMID: 33854102 DOI: 10.1038/s41598-021-87387-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Liu W, Xu L, Wang X, Zhang D, Sun G, Wang M, Wang M, Han Y, Chai R, Wang H. PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage. Autophagy 2021;:1-23. [PMID: 33749526 DOI: 10.1080/15548627.2021.1905466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
19 Tang Q, Wang X, Jin H, Mi Y, Liu L, Dong M, Chen Y, Zou Z. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 2021;163:60-71. [PMID: 33775853 DOI: 10.1016/j.ejpb.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ibrahim MA, Albahlol IA, Wani FA, Abd-Eltawab Tammam A, Kelleni MT, Sayeed MU, Abd El-Fadeal NM, Mohamed AA. Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis. Chem Biol Interact 2021;338:109402. [PMID: 33587916 DOI: 10.1016/j.cbi.2021.109402] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
21 Stanford JK, Bosworth NA, Morgan DS, Chen T, Spankovich C. A clinically derived guinea pig dosing model of cisplatin ototoxicity. Hear Res 2021;404:108202. [PMID: 33621791 DOI: 10.1016/j.heares.2021.108202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Liu YQ, Wang XL, He DH, Cheng YX. Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine 2021;80:153402. [PMID: 33203590 DOI: 10.1016/j.phymed.2020.153402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
23 Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Woolford K, Franke J, Ramkumar V, Rybak L. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin Drug Metab Toxicol 2020;16:965-82. [PMID: 32757852 DOI: 10.1080/17425255.2020.1806235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Naples JG, Ruckenstein MJ, Singh J, Cox BC, Li D. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model. Otol Neurotol 2020;41:115-22. [PMID: 31746818 DOI: 10.1097/MAO.0000000000002417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kashyap T, Nath N, Mishra P, Jha A, Nagini S, Mishra R. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin‐resistance, invasion and stemness acquisition. Head & Neck 2020;42:3282-94. [DOI: 10.1002/hed.26373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Yu D, Gu J, Chen Y, Kang W, Wang X, Wu H. Current Strategies to Combat Cisplatin-Induced Ototoxicity. Front Pharmacol 2020;11:999. [PMID: 32719605 DOI: 10.3389/fphar.2020.00999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
27 Farooqi AA, Pinheiro M, Granja A, Farabegoli F, Reis S, Attar R, Sabitaliyevich UY, Xu B, Ahmad A. EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways. Cancers (Basel) 2020;12:E951. [PMID: 32290543 DOI: 10.3390/cancers12040951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
28 Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets. Trends in Molecular Medicine 2019;25:1123-32. [DOI: 10.1016/j.molmed.2019.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
29 Prasad KN, Bondy SC. Increased oxidative stress, inflammation, and glutamate: Potential preventive and therapeutic targets for hearing disorders. Mech Ageing Dev 2020;185:111191. [PMID: 31765645 DOI: 10.1016/j.mad.2019.111191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
30 Qian Q, Chen W, Cao Y, Cao Q, Cui Y, Li Y, Wu J. Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine. Oxid Med Cell Longev 2019;2019:9240426. [PMID: 31583051 DOI: 10.1155/2019/9240426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
31 Wei R, Penso NEC, Hackman RM, Wang Y, Mackenzie GG. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine. Nutrients 2019;11:E1856. [PMID: 31405071 DOI: 10.3390/nu11081856] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
32 Zhang Y, Chen D, Zhao L, Li W, Ni Y, Chen Y, Li H. Nfatc4 Deficiency Attenuates Ototoxicity by Suppressing Tnf-Mediated Hair Cell Apoptosis in the Mouse Cochlea. Front Immunol 2019;10:1660. [PMID: 31379853 DOI: 10.3389/fimmu.2019.01660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Jiang M, Li H, Johnson A, Karasawa T, Zhang Y, Meier WB, Taghizadeh F, Kachelmeier A, Steyger PS. Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss. Sci Adv 2019;5:eaaw1836. [PMID: 31328162 DOI: 10.1126/sciadv.aaw1836] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
34 Sheth S, Sheehan K, Dhukhwa A, Al Aameri RFH, Mamillapalli C, Mukherjea D, Rybak LP, Ramkumar V. Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss. Sci Rep 2019;9:9571. [PMID: 31267026 DOI: 10.1038/s41598-019-45964-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
35 Rosati R, Shahab M, Neumann WL, Jamesdaniel S. Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells. Exp Cell Res 2019;381:105-11. [PMID: 31078568 DOI: 10.1016/j.yexcr.2019.05.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention. Semin Hear 2019;40:197-204. [PMID: 31036996 DOI: 10.1055/s-0039-1684048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
37 Fujimoto C, Yamasoba T. Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review. Antioxidants (Basel) 2019;8:E109. [PMID: 31022870 DOI: 10.3390/antiox8040109] [Cited by in Crossref: 22] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
38 Bhatta P, Dhukhwa A, Sheehan K, Al Aameri RFH, Borse V, Ghosh S, Sheth S, Mamillapalli C, Rybak L, Ramkumar V, Mukherjea D. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea. Sci Rep 2019;9:4131. [PMID: 30858408 DOI: 10.1038/s41598-019-40425-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
39 Pang J, Xiong H, Zhan T, Cheng G, Jia H, Ye Y, Su Z, Chen H, Lin H, Lai L, Ou Y, Xu Y, Chen S, Huang Q, Liang M, Cai Y, Zhang X, Xu X, Zheng Y, Yang H. Sirtuin 1 and Autophagy Attenuate Cisplatin-Induced Hair Cell Death in the Mouse Cochlea and Zebrafish Lateral Line. Front Cell Neurosci 2018;12:515. [PMID: 30692914 DOI: 10.3389/fncel.2018.00515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
40 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 108] [Cited by in F6Publishing: 146] [Article Influence: 27.0] [Reference Citation Analysis]
41 Castañeda R, Natarajan S, Jeong SY, Hong BN, Kang TH. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery? J Ethnopharmacol 2019;231:409-28. [PMID: 30439402 DOI: 10.1016/j.jep.2018.11.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
42 Goyal Y, Koul A, Ranawat P. Ellagic acid ameliorates cisplatin toxicity in chemically induced colon carcinogenesis. Mol Cell Biochem 2019;453:205-15. [DOI: 10.1007/s11010-018-3446-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
43 Ghosh S, Sheth S, Sheehan K, Mukherjea D, Dhukhwa A, Borse V, Rybak LP, Ramkumar V. The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss. Front Cell Neurosci 2018;12:271. [PMID: 30186120 DOI: 10.3389/fncel.2018.00271] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
44 Shi J, Zhang M, Zhang L, Deng H. Epigallocatechin-3-gallate attenuates microcystin-LR-induced apoptosis in human umbilical vein endothelial cells through activation of the NRF2/HO-1 pathway. Environ Pollut 2018;239:466-72. [PMID: 29679944 DOI: 10.1016/j.envpol.2018.04.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
45 Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Front Cell Neurosci 2017;11:338. [PMID: 29163050 DOI: 10.3389/fncel.2017.00338] [Cited by in Crossref: 117] [Cited by in F6Publishing: 150] [Article Influence: 23.4] [Reference Citation Analysis]